NetworkNewsBreaks – NextPlat Corp (NASDAQ: NXPL)
Post# of 126
NextPlat (NASDAQ: NXPL, NXPLW) has secured vendor approval from JD.com, China’s largest self-operated e-Commerce retailer, to sell OPKO Health Europe’s branded health, wellness, and veterinary products. Under an exclusive agreement with OPKO Health Europe, NextPlat will begin listing nutraceutical products for bone and joint health, nutrition, and immunity on JD.com in early 2025, with plans to expand offerings to include innovative veterinary care products pending regulatory clearance. Leveraging JD.com’s platform, which serves over 560 million annual users, this initiative aligns with the growing demand for premium healthcare products in China, where the nutraceutical market is projected to reach $100 billion by 2025. NextPlat’s President, David Phipps, highlighted this development as a significant step in expanding the company’s e-Commerce footprint and driving product sales in China.
NOTE TO INVESTORS: The latest news and updates relating to NXPL are available in the company’s newsroom at https://nnw.fm/NXPL
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or republished: http://NNW.fm/Disclaimer